Issue link: https://htpgraphics.uberflip.com/i/108176
AWARDS UMIP AWARDS AT THE FLS RESEARCH SYMPOSIUM We would like to acknowledge the dedication of researchers involved in technology commercialisation activities through the introduction of awards and prizes for commercial success. At the Faculty of Life Sciences Research Symposium in September, we sponsored the "Most Promising New Innovation" award and co-sponsored the award for The "Best New Industrial Collaboration." IL1-‚ release in the central nervous system. The "Best New Industrial Collaboration" award was won by Dr Kathy Hentges Gurney for her industrial collaboration with Syngenta on studying developmental toxicity pathways to inform their product development process. UMIP Commercialisation Executive, Dr Arnaud Garçon, presented the prize of iPads to both winners. The "Most Promising New Innovation" award was won by Dr David Brough for his UMIP Proof-of-Principle funded project which focused on a new approach to inhibition of o MANCHESTER TEAM TRIUMPHS IN COMPETITION TO BE BIOTECHNOLOGY STARS OF THE FUTURE place in the December final. CosmoClear's product provides a unique alternative to the treatment of oily complexions as it is safe, natural and effective The competition, hosted by UMIC on day one and organised jointly by the Biotechnology and Biological Sciences Research Council (BBSRC) and the University of Nottingham Institute for Enterprise and Innovation (UNIEI), is open to bioscience researchers and aims to help them commercialise their ideas. A Manchester team has secured a place in the final of a national competition to find the entrepreneurial bioscientists of the future. Enzomax beat off stiff competition from 15 other teams from universities and institutes around the UK in the Biotechnology Young Entrepreneurs Scheme (Biotechnology YES) 2012 competition. They will fly the flag for Manchester later in the month in London at the UK finals where the winning team will collect £1,000, an invitation to attend the BIA Gala Dinner 10 Enzomax (Matthew Styles, AnnaWinona Struck; Sarah Shepherd; Brian Law; James Leigh) have a proprietary platform technology, known as Enzomax SHIELD™, which they use to deliver cost-effective solutions for maximising the performance of enzymes in industrial biotechnology. The North West heat was held over three days at UMIC's Core Technology Facility and Manchester United Football Club. Regional professionals, including representatives from UMIP and our network of advisors and professional associates offered mentoring sessions to the researchers during the competition. Teams also attended workshops and seminars to hear advice and received tips on how to develop their ideas into commerciallyviable opportunities. Enzomax will be joined by CosmoClear (University College London) who also secured a Each team was required to present an idea that is based on a hypothetical biotech idea. and the opportunity to attend the premier regional US Business Plan Competition at Rice University in Houston, Texas. On the final day of the event they presented their concept to a judging panel of biotechnology and business experts. Dr Rich Ferrie, Director of IP commercialisation and Head of UMIP, commented: "This competition is a key part of the annual schedule of events at Manchester. It gives young bio scientists an opportunity to learn about business creation from a range of seasoned professionals, all of whom give their valuable time for free. This year's competition attracted teams from right across the North of England, and even from London, and it was a pleasure to Chair one of the panels of judges and witness for myself how much the teams had learned in such a short period. We now wish the winning teams the best of luck for the UK Finals where they have every chance of overall success." www.biotechnologyyes.co.uk